23,996 XNAS Volume
XNAS 20 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Bradley Sitko | Chief Investment Officer | Purchase of securities on an exchange or from another person at price $ 25.90 per share. | 31 Dec 2024 | 300 | 9,150 (0%) | 0% | 25.9 | 7,770 | Common Stock |
| Owen P. Hughes | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 53,360 | 56,860 (0%) | 0% | 0 | Common Stock | |
| Owen P. Hughes | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 53,360 | 221,640 | - | - | Performance Stock Units | |
| Owen P. Hughes | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.95 per share. | 11 Nov 2024 | 21,881 | 34,979 (0%) | 0% | 30.0 | 655,336 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 29.94 per share. | 11 Nov 2024 | 9,775 | 14,553 (0%) | 0% | 29.9 | 292,664 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 17,773 | 24,328 (0%) | 0% | 0 | Common Stock | |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 17,773 | 73,827 | - | - | Performance Stock Units | |
| Jack L. Wyszomierski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 6,070 | 12,533 (0%) | 0% | 0 | Common Stock | |
| Heather L. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 9,763 | 9,763 | - | - | Non-Qualified Share Option (right to buy) | |
| Joseph M. Limber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 9,763 | 9,763 | - | - | Non-Qualified Share Option (right to buy) | |
| Perry D Matthew | Director, See Explanation of Responses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 6,070 | 17,869 (0%) | 0% | 0 | Common Stock | |
| Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 9,763 | 9,763 | - | - | Non-Qualified Share Option (right to buy) | |
| Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 4,881 | 4,881 | - | - | Non-Qualified Share Option (right to buy) | |
| Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 3,035 | 3,035 (0%) | 0% | 0 | Common Stock | |
| Owen P. Hughes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 275,000 | 275,000 | - | - | Performance Stock Units | |
| Owen Hughes | Director, Interim CEO | Purchase of securities on an exchange or from another person at price $ 23.79 per share. | 23 May 2023 | 1,032 | 2,000 (0%) | 0% | 23.8 | 24,551 | Depositary Shares - 8.375% B Cumulative Stock |
| Owen Hughes | Director, Interim CEO | Purchase of securities on an exchange or from another person at price $ 23.49 per share. | 23 May 2023 | 768 | 968 (0%) | 0% | 23.5 | 18,040 | Depositary Shares - 8.375% B Cumulative Stock |
| Owen Hughes | Director, Interim CEO | Purchase of securities on an exchange or from another person at price $ 23.33 per share. | 23 May 2023 | 200 | 200 (0%) | 0% | 23.3 | 4,666 | Depositary Shares - 8.375% B Cumulative Stock |
| Bradley Sitko | Chief Investment Officer | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 23 May 2023 | 850 | 3,850 (0%) | 0% | 19 | 16,150 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 91,600 | 91,600 | - | - | Performance Stock Units | |
| Bradley Sitko | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 30,200 | 30,200 | - | - | Performance Stock Units | |
| Bradley Sitko | Chief Investment Officer | Purchase of securities on an exchange or from another person at price $ 19.50 per share. | 18 May 2023 | 1,000 | 3,000 (0%) | 0% | 19.5 | 19,500 | Common Stock |
| Jack L. Wyszomierski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 10,967 | 10,967 | - | - | Non-Qualified Share Option (right to buy) | |
| Heather L. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 10,967 | 10,967 | - | - | Non-Qualified Share Option (right to buy) | |
| Joseph M. Limber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 10,967 | 10,967 | - | - | Non-Qualified Share Option (right to buy) | |
| Perry D Matthew | Director, See Explanation of Responses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 10,967 | 10,967 | - | - | Non-Qualified Share Option (right to buy) | |
| Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 10,967 | 10,967 | - | - | Non-Qualified Share Option (right to buy) | |
| Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 10,967 | 10,967 | - | - | Non-Qualified Share Option (right to buy) | |
| Bradley Sitko | Chief Investment Officer | Purchase of securities on an exchange or from another person at price $ 23.20 per share. | 16 May 2023 | 100 | 1,900 (0%) | 0% | 23.2 | 2,320 | Depositary Shares - 8.375% B Cumulative Stock |
| Bradley Sitko | Chief Investment Officer | Purchase of securities on an exchange or from another person at price $ 23.19 per share. | 16 May 2023 | 300 | 1,800 (0%) | 0% | 23.2 | 6,957 | Depositary Shares - 8.375% B Cumulative Stock |
| Bradley Sitko | Chief Investment Officer | Purchase of securities on an exchange or from another person at price $ 23.25 per share. | 16 May 2023 | 100 | 2,000 (0%) | 0% | 23.3 | 2,325 | Depositary Shares - 8.375% B Cumulative Stock |
| Bradley Sitko | Chief Investment Officer | Purchase of securities on an exchange or from another person at price $ 18.65 per share. | 12 May 2023 | 43 | 43 (0%) | 0% | 18.7 | 802 | Common Stock |
| Bradley Sitko | Chief Investment Officer | Purchase of securities on an exchange or from another person at price $ 23.40 per share. | 12 May 2023 | 1,500 | 1,500 (0%) | 0% | 23.4 | 35,100 | Depositary Shares - 8.375% B Cumulative Stock |
| Bradley Sitko | Chief Investment Officer | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 12 May 2023 | 1,957 | 2,000 (0%) | 0% | 19 | 37,183 | Common Stock |
| Owen Hughes | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Owen Hughes | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Bradley Sitko | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| Bradley Sitko | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Thomas Burns | SVP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 31.19 per share. | 15 Jul 2022 | 3,212 | 12,727 (0%) | 0% | 31.2 | 100,175 | Common Stock |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 15 Jul 2022 | 25,000 | 36,822 (0%) | 0% | 4.0 | 100,750 | Common Stock |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 29.55 per share. | 15 Jul 2022 | 20,883 | 15,939 (0%) | 0% | 29.6 | 617,095 | Common Stock |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 31.86 per share. | 15 Jul 2022 | 905 | 11,822 (0%) | 0% | 31.9 | 28,834 | Common Stock |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 25,000 | 218,056 | - | - | Stock Option (Right to Buy) | |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 31.66 per share. | 15 Jul 2022 | 2,000 | 6,555 (0%) | 0% | 31.7 | 63,321 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 15 Jul 2022 | 2,000 | 8,555 (0%) | 0% | 4.0 | 8,060 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 2,000 | 75,778 | - | - | Stock Option (Right to Buy) | |
| Jack L. Wyszomierski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,996 | 8,996 | - | - | Non-Qualified Share Option (right to buy) | |
| Heather L. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,996 | 8,996 | - | - | Non-Qualified Share Option (right to buy) | |
| Joseph M. Limber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,996 | 8,996 | - | - | Non-Qualified Share Option (right to buy) | |
| Perry D Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,996 | 8,996 | - | - | Non-Qualified Share Option (right to buy) | |
| W. Denman Van Ness | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,996 | 8,996 | - | - | Non-Qualified Share Option (right to buy) | |
| Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,996 | 8,996 | - | - | Non-Qualified Share Option (right to buy) | |
| Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,996 | 8,996 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 2,339 | 103,911 | - | - | Stock Option (Right to Buy) | |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 21 Mar 2022 | 50,000 | 61,822 (0%) | 0% | 4.0 | 201,500 | Common Stock |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 21 Mar 2022 | 50,000 | 11,822 (0%) | 0% | 29.0 | 1,450,250 | Common Stock |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 21 Mar 2022 | 2,339 | 14,161 (0%) | 0% | 4.0 | 9,426 | Common Stock |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 21 Mar 2022 | 2,339 | 11,822 (0%) | 0% | 30.0 | 70,209 | Common Stock |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 21 Mar 2022 | 1,111 | 12,933 (0%) | 0% | 4.0 | 4,477 | Common Stock |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 21 Mar 2022 | 1,111 | 11,822 (0%) | 0% | 30.0 | 33,348 | Common Stock |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 50,000 | 106,250 | - | - | Stock Option (Right to Buy) | |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 1,111 | 102,800 | - | - | Stock Option (Right to Buy) | |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 21 Mar 2022 | 12,000 | 18,555 (0%) | 0% | 4.0 | 48,360 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 161 | 15,500 | - | - | Stock Option (Right to Buy) | |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 2,339 | 15,661 | - | - | Stock Option (Right to Buy) | |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 12,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 21 Mar 2022 | 161 | 6,555 (0%) | 0% | 30 | 4,830 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 21 Mar 2022 | 161 | 6,716 (0%) | 0% | 4.0 | 649 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 21 Mar 2022 | 2,339 | 6,555 (0%) | 0% | 30.0 | 70,209 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 21 Mar 2022 | 2,339 | 8,894 (0%) | 0% | 4.0 | 9,426 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 21 Mar 2022 | 12,000 | 6,555 (0%) | 0% | 29.0 | 348,060 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 28,000 | 28,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| James R. Neal | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2021 | 60,000 | 60,000 | - | - | Non-Qualified Share Option (right to buy) | |
| Heather L. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 13,136 | 13,136 | - | - | Non-Qualified Share Option (right to buy) | |
| Heather L. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 4,146 | 4,146 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 35.13 per share. | 25 Jun 2021 | 686 | 11,821 (0%) | 0% | 35.1 | 24,101 | Common Shares |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 33.36 per share. | 25 Jun 2021 | 7,170 | 13,678 (0%) | 0% | 33.4 | 239,202 | Common Shares |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 34.30 per share. | 25 Jun 2021 | 1,171 | 12,507 (0%) | 0% | 34.3 | 40,170 | Common Shares |
| Jack L. Wyszomierski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 5,101 | 5,101 | - | - | Non-Qualified Share Option (right to buy) | |
| Joseph M. Limber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 5,101 | 5,101 | - | - | Non-Qualified Share Option (right to buy) | |
| Perry D Matthew | Director, See Explanation of Responses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 5,101 | 5,101 | - | - | Non-Qualified Stock Option (right to buy) | |
| W. Denman Van Ness | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 5,101 | 5,101 | - | - | Non-Qualified Share Option (right to buy) | |
| Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 5,101 | 5,101 | - | - | Non-Qualified Share Option (right to buy) | |
| Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 5,101 | 5,101 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Director, CEO | Grant, award, or other acquisition of securities at price $ 25.00 per share. | 09 Apr 2021 | 8,000 | 8,000 | - | 25 | 200,000 | Depositary Shares - 8.375% B Cumulative Stock |
| Thomas Burns | SVP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 25.00 per share. | 09 Apr 2021 | 1,000 | 1,000 | - | 25 | 25,000 | Depositary Shares - 8.375% B Cumulative Stock |
| W. Denman Van Ness | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 15 Mar 2021 | 3,333 | 15,643 (0%) | 0% | 4.0 | 13,432 | Common Stock |
| W. Denman Van Ness | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 3,333 | 0 | - | - | Non-Qualified Share Option (Right to Buy) | |
| W. Denman Van Ness | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 2,366 | 0 | - | - | Non-Qualified Share Option (Right to Buy) | |
| W. Denman Van Ness | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.40 per share. | 15 Mar 2021 | 2,366 | 12,310 (0%) | 0% | 19.4 | 45,900 | Common Stock |
| James R. Neal | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 60,268 | 60,268 | - | - | Non-Qualified Share Option (right to buy) | |
| Thomas Burns | SVP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 20,055 | 20,055 | - | - | Non-Qualified Stock Option (right to buy) | |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 15 Dec 2020 | 26,000 | 46,849 (0%) | 0% | 5.5 | 143,000 | Common Stock |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 26,000 | 0 | - | - | Stock Option (Right to Buy) | |
| James R. Neal | Director, CEO | Grant, award, or other acquisition of securities at price $ 25.00 per share. | 15 Dec 2020 | 8,000 | 8,000 | - | 25 | 200,000 | 8.625% Series A Cumulative Perpetual Preferred Stock |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 42.04 per share. | 15 Dec 2020 | 5,706 | 20,849 (0%) | 0% | 42.0 | 239,900 | Common Stock |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 41.15 per share. | 15 Dec 2020 | 20,294 | 26,555 (0%) | 0% | 41.1 | 835,098 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 15 Dec 2020 | 15,000 | 21,555 (0%) | 0% | 4.0 | 60,450 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 15,000 | 7,000 | - | - | Stock Option (Right to Buy) | |
| Thomas Burns | SVP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 25.00 per share. | 15 Dec 2020 | 2,000 | 2,000 | - | 25 | 50,000 | 8.625% Series A Cumulative Perpetual Preferred Stock |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 42.04 per share. | 15 Dec 2020 | 5,607 | 6,555 (0%) | 0% | 42.0 | 235,744 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 41.02 per share. | 15 Dec 2020 | 9,393 | 12,162 (0%) | 0% | 41.0 | 385,342 | Common Stock |
| Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 25.00 per share. | 15 Dec 2020 | 4,000 | 4,000 | - | 25 | 100,000 | 8.625% Series A Cumulative Perpetual Preferred Stock |
| Perry D Matthew | Director, See Explanation of Responses | Purchase of securities on an exchange or from another person at price $ 25.00 per share. | 11 Dec 2020 | 200,000 | 200,000 | - | 25 | 5,000,000 | 8.625% Series A Cumulative Perpetual Preferred Stock |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 20 Nov 2020 | 6,874 | 27,723 (0%) | 0% | 5.5 | 37,807 | Common Stock |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 13,126 | 26,000 | - | - | Stock Option (Right to Buy) | |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 6,874 | 39,126 | - | - | Stock Option (Right to Buy) | |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 32.96 per share. | 20 Nov 2020 | 13,126 | 20,849 (0%) | 0% | 33.0 | 432,662 | Common Stock |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 20 Nov 2020 | 13,126 | 33,975 (0%) | 0% | 5.5 | 72,193 | Common Stock |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 33.35 per share. | 20 Nov 2020 | 426 | 20,849 (0%) | 0% | 33.4 | 14,208 | Common Stock |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 32.46 per share. | 20 Nov 2020 | 6,448 | 21,275 (0%) | 0% | 32.5 | 209,315 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 20 Nov 2020 | 5,125 | 11,680 (0%) | 0% | 4.0 | 20,654 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 20 Nov 2020 | 6,875 | 13,430 (0%) | 0% | 4.0 | 27,706 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 32.46 per share. | 20 Nov 2020 | 6,449 | 6,981 (0%) | 0% | 32.5 | 209,347 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 33.35 per share. | 20 Nov 2020 | 426 | 6,555 (0%) | 0% | 33.4 | 14,208 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 32.93 per share. | 20 Nov 2020 | 5,125 | 6,555 (0%) | 0% | 32.9 | 168,752 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 6,875 | 27,125 | - | - | Stock Option (Right to Buy) | |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 5,125 | 22,000 | - | - | Stock Option (Right to Buy) | |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2020 | 10,000 | 46,000 | - | - | Stock Option (Right to Buy) | |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 05 Nov 2020 | 10,000 | 30,849 (0%) | 0% | 5.5 | 55,000 | Common Stock |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 05 Nov 2020 | 727 | 20,849 (0%) | 0% | 27.5 | 19,993 | Common Stock |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 25.90 per share. | 05 Nov 2020 | 9,273 | 21,576 (0%) | 0% | 25.9 | 240,212 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2020 | 8,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 05 Nov 2020 | 8,000 | 14,555 (0%) | 0% | 4.0 | 32,240 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 25.98 per share. | 05 Nov 2020 | 7,274 | 7,281 (0%) | 0% | 26.0 | 188,943 | Common Stock |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 05 Nov 2020 | 726 | 6,555 (0%) | 0% | 27.5 | 19,965 | Common Stock |
| Natasha A. Hernday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 13,251 | 13,251 | - | - | Non-Qualified Share Option (right to buy) | |
| Jack L. Wyszomierski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 6,152 | 6,152 | - | - | Non-Qualified Share Option (right to buy) | |
| Joseph M. Limber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 6,152 | 6,152 | - | - | Non-Qualified Share Option (right to buy) | |
| Perry D Matthew | Other, See Explanation of Responses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 6,152 | 6,152 | - | - | Non-Qualified Stock Option (right to buy) | |
| W. Denman Van Ness | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 6,152 | 6,152 | - | - | Non-Qualified Share Option (right to buy) | |
| Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 6,152 | 6,152 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Director, CEO | Purchase of securities on an exchange or from another person at price $ 14.50 per share. | 23 Mar 2020 | 1,000 | 20,849 (0%) | 0% | 14.5 | 14,500 | Common Shares |
| James R. Neal | Director, CEO | Purchase of securities on an exchange or from another person at price $ 16.41 per share. | 20 Mar 2020 | 1,000 | 19,849 (0%) | 0% | 16.4 | 16,410 | Common Shares |
| James R. Neal | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2020 | 66,200 | 66,200 | - | - | Non Qualified Stock Option (right to buy) | |
| Thomas Burns | SVP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2020 | 22,000 | 22,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| James R. Neal | Director, CEO | 23 Dec 2019 | 1,180 | 18,849 (0%) | 0% | 22 | 25,960 | Common Shares | |
| James R. Neal | Director, CEO | 23 Dec 2019 | 1,180 | 0 | - | - | Subscription Rights (right to buy) | ||
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 06 Nov 2019 | 4,348 | 22,017 (0%) | 0% | 5.5 | 23,914 | Common Stock |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2019 | 4,348 | 56,000 | - | - | Stock Option (Right to Buy) | |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 06 Nov 2019 | 4,348 | 17,669 (0%) | 0% | 22 | 95,656 | Common Stock |
| James R. Neal | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 18 Sep 2019 | 6,370 | 24,039 (0%) | 0% | 5.5 | 35,035 | Common Stock |
| James R. Neal | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2019 | 5,452 | 60,348 | - | - | Stock Option (right to buy) | |
| James R. Neal | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2019 | 6,370 | 65,800 | - | - | Stock Option (right to buy) | |
| James R. Neal | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2019 | 3,830 | 72,170 | - | - | Stock Option (right to buy) | |
| James R. Neal | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.23 per share. | 18 Sep 2019 | 5,452 | 17,669 (0%) | 0% | 20.2 | 110,271 | Common Stock |
| James R. Neal | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 18 Sep 2019 | 5,452 | 23,121 (0%) | 0% | 5.5 | 29,986 | Common Stock |
| James R. Neal | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.73 per share. | 18 Sep 2019 | 2,642 | 17,669 (0%) | 0% | 21.7 | 57,415 | Common Stock |
| James R. Neal | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.96 per share. | 18 Sep 2019 | 3,830 | 17,669 (0%) | 0% | 22.0 | 84,113 | Common Stock |
| James R. Neal | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 18 Sep 2019 | 3,830 | 21,499 (0%) | 0% | 5.5 | 21,065 | Common Stock |
| James R. Neal | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.69 per share. | 18 Sep 2019 | 3,728 | 20,311 (0%) | 0% | 20.7 | 77,129 | Common Stock |
| Thomas Burns | Sr. VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 18 Sep 2019 | 3,829 | 10,384 (0%) | 0% | 4.0 | 15,431 | Common Stock |
| Thomas Burns | Sr. VP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 21.96 per share. | 18 Sep 2019 | 3,829 | 6,555 (0%) | 0% | 22.0 | 84,091 | Common Stock |
| Thomas Burns | Sr. VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 18 Sep 2019 | 4,171 | 10,726 (0%) | 0% | 4.0 | 16,809 | Common Stock |
| Thomas Burns | Sr. VP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 21.35 per share. | 18 Sep 2019 | 3,671 | 7,055 (0%) | 0% | 21.4 | 78,378 | Common Stock |
| Thomas Burns | Sr. VP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 21.84 per share. | 18 Sep 2019 | 500 | 6,555 (0%) | 0% | 21.8 | 10,918 | Common Stock |
| Thomas Burns | Sr. VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2019 | 3,829 | 46,171 | - | - | Stock Option (right to buy) | |
| Thomas Burns | Sr. VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2019 | 4,171 | 42,000 | - | - | Stock Option (right to buy) | |
| Jack L. Wyszomierski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2019 | 8,167 | 8,167 | - | - | Non-Qualified Share Option (right to buy) | |
| Joseph M. Limber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2019 | 8,167 | 8,167 | - | - | Non-Qualified Share Option (right to buy) | |
| Perry D Matthew | Other, See Explanation of Responses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2019 | 8,167 | 8,167 | - | - | Non-Qualified Stock Option (right to buy) | |
| W. Denman Van Ness | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2019 | 8,167 | 8,167 | - | - | Non-Qualified Share Option (right to buy) | |
| Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2019 | 8,167 | 8,167 | - | - | Non-Qualified Share Option (right to buy) | |
| W. Denman Van Ness | Director | Sale of securities on an exchange or to another person at price $ 14.71 per share. | 10 May 2019 | 130 | 0 (0%) | 0% | 14.7 | 1,912 | Common Stock |
| James R. Neal | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 60,000 | 60,000 | - | - | Non-Qualified Share Option (right to buy) | |
| Thomas Burns | SVP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 23,000 | 23,000 | - | - | Non-Qualified Share Option (right to buy) | |
| Deepshikha Datta | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 50,000 | 50,000 | - | - | Non-Qualified Share Option (right to buy) | |
| Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2019 | 19,979 | 19,979 | - | - | Non-Qualified Share Option (right to buy) | |
| W. Denman Van Ness | None | 20 Dec 2018 | 800 | 9,944 (0%) | 0% | 13 | 10,400 | Common Shares | |
| W. Denman Van Ness | None | 20 Dec 2018 | 800 | 0 | - | - | Subscription Rights (right to buy) | ||
| James R. Neal | Director, CEO | 20 Dec 2018 | 678 | 0 | - | - | Subscription Rights (right to buy) | ||
| James R. Neal | Director, CEO | 20 Dec 2018 | 678 | 21,011 (0%) | 0% | 13 | 8,814 | Common Shares | |
| W. Denman Van Ness | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2018 | 3,026 | 0 | - | - | Non-Qualified Share Option (right to buy) | |
| W. Denman Van Ness | None | Sale of securities on an exchange or to another person at price $ 12.67 per share. | 15 Nov 2018 | 5,528 | 9,144 (0%) | 0% | 12.7 | 70,040 | Common Shares |
| W. Denman Van Ness | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.20 per share. | 15 Nov 2018 | 3,026 | 14,672 (0%) | 0% | 11.2 | 33,891 | Common Shares |
| W. Denman Van Ness | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 15 Nov 2018 | 4,667 | 11,646 (0%) | 0% | 4.0 | 18,808 | Common Shares |
| W. Denman Van Ness | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2018 | 4,667 | 3,333 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Director, CEO | Purchase of securities on an exchange or from another person at price $ 13.26 per share. | 13 Nov 2018 | 4,000 | 20,333 (0%) | 0% | 13.3 | 53,056 | Common Shares |
| Deepshikha Datta | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2018 | 24,000 | 24,000 | - | - | Non-Qualified Share Option (right to buy) | |
| Jack L. Wyszomierski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2018 | 5,052 | 5,052 | - | - | Non-Qualified Share Option (right to buy) | |
| Joseph M. Limber | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2018 | 5,052 | 5,052 | - | - | Non-Qualified Share Option (right to buy) | |
| Perry D Matthew | Other | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2018 | 5,052 | 5,052 | - | - | Non-Qualified Stock Option (right to buy) | |
| W. Denman Van Ness | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2018 | 5,052 | 5,052 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 24.42 per share. | 26 Apr 2018 | 15,655 | 16,333 (0%) | 0% | 24.4 | 382,236 | Common Shares |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 24.69 per share. | 26 Apr 2018 | 8,345 | 16,333 (0%) | 0% | 24.7 | 206,050 | Common Shares |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 26 Apr 2018 | 15,655 | 31,988 (0%) | 0% | 5.5 | 86,103 | Common Shares |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 26 Apr 2018 | 8,345 | 24,678 (0%) | 0% | 5.5 | 45,898 | Common Shares |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2018 | 15,655 | 76,000 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2018 | 8,345 | 91,655 | - | - | Non-Qualified Share Option (right to buy) | |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2018 | 2,655 | 24,000 | - | - | Non-Qualified Share Option (right to buy) | |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 26 Apr 2018 | 8,345 | 14,900 (0%) | 0% | 5.5 | 45,898 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 24.69 per share. | 26 Apr 2018 | 8,345 | 6,555 (0%) | 0% | 24.7 | 206,050 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 26 Apr 2018 | 2,655 | 9,210 (0%) | 0% | 5.5 | 14,603 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 24.77 per share. | 26 Apr 2018 | 2,655 | 6,555 (0%) | 0% | 24.8 | 65,757 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2018 | 8,345 | 26,655 | - | - | Non-Qualified Share Option (right to buy) | |
| Deepshikha Datta | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2018 | 80,000 | 80,000 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2018 | 30,000 | 30,000 | - | - | Non-Qualified Share Option (right to buy) | |
| Thomas Burns | SVP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2018 | 25,000 | 25,000 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 13 Nov 2017 | 8,583 | 24,916 (0%) | 0% | 4.0 | 34,589 | Common Shares |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 27.13 per share. | 13 Nov 2017 | 3,519 | 21,397 (0%) | 0% | 27.1 | 95,468 | Common Shares |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 29.05 per share. | 13 Nov 2017 | 3,564 | 17,833 (0%) | 0% | 29.0 | 103,532 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2017 | 8,392 | 77,778 | - | - | Non-Qualified Share Option (right to buy) | |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 28.98 per share. | 13 Nov 2017 | 3,180 | 7,405 (0%) | 0% | 29.0 | 92,152 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 27.16 per share. | 13 Nov 2017 | 2,817 | 10,585 (0%) | 0% | 27.2 | 76,512 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2017 | 6,983 | 93,017 | - | - | Non-Qualified Share Option (right to buy) | |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2017 | 6,847 | 86,170 | - | - | Non-Qualified Share Option (right to buy) | |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 13 Nov 2017 | 6,847 | 13,402 (0%) | 0% | 4.0 | 27,593 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 31.77 per share. | 13 Nov 2017 | 486 | 6,555 (0%) | 0% | 31.8 | 15,438 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 30.93 per share. | 13 Nov 2017 | 6,497 | 7,041 (0%) | 0% | 30.9 | 200,981 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 13 Nov 2017 | 6,983 | 13,538 (0%) | 0% | 4.0 | 28,141 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 27.44 per share. | 13 Nov 2017 | 200 | 6,555 (0%) | 0% | 27.4 | 5,487 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 27.04 per share. | 13 Nov 2017 | 8,192 | 6,755 (0%) | 0% | 27.0 | 221,491 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 13 Nov 2017 | 8,392 | 14,947 (0%) | 0% | 4.0 | 33,820 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 30.49 per share. | 13 Nov 2017 | 250 | 6,555 (0%) | 0% | 30.5 | 7,622 | Common Shares |
| Thomas Burns | SVP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 29.61 per share. | 13 Nov 2017 | 600 | 6,805 (0%) | 0% | 29.6 | 17,768 | Common Shares |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 29.42 per share. | 13 Nov 2017 | 900 | 16,933 (0%) | 0% | 29.4 | 26,477 | Common Shares |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 30.45 per share. | 13 Nov 2017 | 600 | 16,333 (0%) | 0% | 30.5 | 18,270 | Common Shares |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2017 | 11,568 | 300,932 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2017 | 8,583 | 292,349 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2017 | 26,145 | 266,204 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 27.44 per share. | 13 Nov 2017 | 2,200 | 16,333 (0%) | 0% | 27.4 | 60,366 | Common Shares |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 13 Nov 2017 | 23,945 | 18,533 (0%) | 0% | 27.0 | 646,400 | Common Shares |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 13 Nov 2017 | 26,145 | 42,478 (0%) | 0% | 4.0 | 105,364 | Common Shares |
| James R. Neal | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 13 Nov 2017 | 11,568 | 27,901 (0%) | 0% | 4.0 | 46,619 | Common Shares |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 30.79 per share. | 13 Nov 2017 | 11,084 | 16,817 (0%) | 0% | 30.8 | 341,300 | Common Shares |
| James R. Neal | Director, CEO | Sale of securities on an exchange or to another person at price $ 31.77 per share. | 13 Nov 2017 | 484 | 16,333 (0%) | 0% | 31.8 | 15,375 | Common Shares |
| Jack L. Wyszomierski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2017 | 2,366 | 2,366 | - | - | Non-Qualified Share Option (right to buy) | |
| Joseph M. Limber | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2017 | 2,366 | 2,366 | - | - | Non-Qualified Share Option (right to buy) | |
| W. Denman Van Ness | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2017 | 2,366 | 2,366 | - | - | Non-Qualified Share Option (right to buy) | |
| John Varian | None | Sale of securities on an exchange or to another person at price $ 6.24 per share. | 16 May 2017 | 39,540 | 2,344 (0%) | 0% | 6.2 | 246,919 | Common Shares |
| James R. Neal | Other | Sale of securities on an exchange or to another person at price $ 5.40 per share. | 21 Mar 2017 | 5,105 | 15,366 (0%) | 0% | 5.4 | 27,569 | Common Shares |
| Thomas Burns | VP, Finance & Chief Financial | Sale of securities on an exchange or to another person at price $ 5.40 per share. | 21 Mar 2017 | 2,598 | 6,555 (0%) | 0% | 5.4 | 14,030 | Common Shares |
| Perry D Matthew | Other | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2017 | 15,222 | 15,222 | - | - | Non-Qualified Stock Option (right to buy) | |
| Perry D Matthew | Other | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2017 | 11,799 | 11,799 (0%) | 0% | 0 | Common Stock, $0.0075 par value per share | |
| Jack L. Wyszomierski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2017 | 8,000 | 8,000 | - | - | Non-Qualified Share Option (right to buy) | |
| Peter Barton Hutt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2017 | 8,000 | 8,000 | - | - | Non-Qualified Share Option (right to buy) | |
| Timothy P. Walbert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2017 | 8,000 | 8,000 | - | - | Non-Qualified Share Option (right to buy) | |
| Joseph M. Limber | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2017 | 8,000 | 8,000 | - | - | Non-Qualified Share Option (right to buy) | |
| John Varian | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2017 | 8,000 | 8,000 | - | - | Non-Qualified Share Option (right to buy) | |
| W. Denman Van Ness | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2017 | 8,000 | 8,000 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Other | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2017 | 312,500 | 312,500 | - | - | Non-Qualified Share Option (right to buy) | |
| Thomas Burns | VP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2017 | 100,000 | 100,000 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Other | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 01 Feb 2017 | 95 | 20,471 (0%) | 0% | 4.5 | 428 | Common Shares |
| James R. Neal | Other | Sale of securities on an exchange or to another person at price $ 4.53 per share. | 01 Feb 2017 | 100 | 20,566 (0%) | 0% | 4.5 | 453 | Common Shares |
| James R. Neal | Other | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2016 | 100,000 | 100,000 | - | - | Non-Qualified Share Option (right to buy) | |
| Thomas Burns | VP, Finance & Chief Financial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2016 | 35,000 | 35,000 | - | - | Non-Qualified Share Option (right to buy) | |
| Patrick J. Scannon | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Dec 2016 | 3,230 | 8,217 | - | - | Common Shares | |
| John Varian | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Dec 2016 | 13,549 | 41,884 | - | - | Common Shares | |
| James R. Neal | VP Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Nov 2016 | 150 | 20,541 | - | - | Common Shares | |
| James R. Neal | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Oct 2016 | 2,500 | 413,839 | - | - | Common Shares | |
| Joseph M. Limber | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 60,532 | 60,532 | - | - | Non-Qualified Share Option (right to buy) | |
| Joseph M. Limber | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 48,246 | 124,219 | - | - | Common Shares | |
| Peter Barton Hutt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 121,064 | 121,064 | - | - | Non-Qualified Share Option (right to buy) | |
| Jack L. Wyszomierski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 60,532 | 60,532 | - | - | Non-Qualified Share Option (right to buy) | |
| Jack L. Wyszomierski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 48,246 | 129,314 | - | - | Common Shares | |
| W. Denman Van Ness | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 60,532 | 60,532 | - | - | Non-Qualified Share Option (right to buy) | |
| W. Denman Van Ness | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 48,246 | 139,596 | - | - | Common Shares | |
| W. Denman Van Ness | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 48,246 | 139,596 | - | - | Common Shares | |
| W. Denman Van Ness | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 60,532 | 60,532 | - | - | Non-Qualified Share Option (right to buy) | |
| Timothy P. Walbert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 60,532 | 60,532 | - | - | Non-Qualified Share Option (right to buy) | |
| Timothy P. Walbert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2016 | 48,246 | 129,314 | - | - | Common Shares | |
| Joseph M. Limber | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2016 | 2,800 | 0 | - | - | Restricted Stock Units | |
| Joseph M. Limber | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2016 | 2,800 | 75,973 | - | - | Common Shares | |
| Jack L. Wyszomierski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2016 | 2,800 | 0 | - | - | Restricted Stock Units | |
| Jack L. Wyszomierski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2016 | 2,800 | 81,068 | - | - | Common Shares | |
| W. Denman Van Ness | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2016 | 3,150 | 0 | - | - | Restricted Stock Units | |
| W. Denman Van Ness | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2016 | 3,150 | 91,350 | - | - | Common Shares | |
| Timothy P. Walbert | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2016 | 2,800 | 0 | - | - | Restricted Stock Units | |
| Timothy P. Walbert | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2016 | 2,800 | 81,068 | - | - | Common Shares | |
| James R. Neal | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Mar 2016 | 19,813 | 411,339 | - | - | Common Shares | |
| Thomas Burns | VP, Finance & Chief Financial | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Mar 2016 | 19,249 | 183,071 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2016 | 12,141 | 0 | - | - | Restricted Stock Units | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2016 | 12,141 | 350,795 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Mar 2016 | 24,194 | 326,601 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Mar 2016 | 14,785 | 228,942 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2016 | 9,500 | 243,727 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2016 | 9,500 | 0 | - | - | Restricted Stock Units | |
| John Varian | Director, CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Mar 2016 | 81,022 | 1,108,673 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2016 | 36,907 | 0 | - | - | Restricted Stock Units | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2016 | 36,907 | 1,189,695 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2016 | 198,330 | 338,654 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2016 | 140,000 | 234,227 | - | - | Common Shares | |
| John Varian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2016 | 541,600 | 1,152,788 | - | - | Common Shares | |
| James R. Neal | Other | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2016 | 248,954 | 431,152 | - | - | Common Shares | |
| Thomas Burns | VP, Finance & Chief Financial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2016 | 108,560 | 202,320 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Feb 2016 | 8,000 | 94,227 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2015 | 1,457 | 120,924 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2015 | 575 | 124,377 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2015 | 6,541 | 13,422 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2015 | 8,721 | 33,801 | - | - | Common Shares | |
| John Varian | Director, CEO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2015 | 8,721 | 27,259 | - | - | Common Shares | |
| James R. Neal | Other | Other type of transaction at price $ 0.00 per share. | 31 Dec 2015 | 4,318 | 182,198 | - | - | Common Shares | |
| James R. Neal | Other | Other type of transaction at price $ 0.00 per share. | 31 Dec 2015 | 703 | 186,947 | - | - | Common Shares | |
| James R. Neal | Other | Other type of transaction at price $ 0.00 per share. | 31 Dec 2015 | 8,721 | 13,192 | - | - | Common Shares | |
| James R. Neal | Other | Other type of transaction at price $ 0.00 per share. | 31 Dec 2015 | 1,775 | 186,244 | - | - | Common Shares | |
| Tom Burns | VP, Finance & Chief Financial | Other type of transaction at price $ 0.00 per share. | 31 Dec 2015 | 6,541 | 13,488 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 28 Dec 2015 | 8,000 | 102,227 | - | - | Common Shares | |
| Joseph M. Limber | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2015 | 5,600 | 73,173 | - | - | Common Shares | |
| Joseph M. Limber | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2015 | 5,600 | 0 | - | - | Restricted Stock Units | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 23 Nov 2015 | 8,000 | 110,227 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Oct 2015 | 8,000 | 118,227 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2015 | 10,801 | 138,292 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2015 | 26,748 | 149,093 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2015 | 26,748 | 0 | - | - | Restricted Stock Units | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2015 | 16,264 | 38,917 | - | - | Restricted Stock Units | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2015 | 6,157 | 109,963 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2015 | 16,264 | 126,227 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2015 | 94,573 | 195,239 | - | - | Restricted Stock Units | |
| John Varian | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2015 | 35,799 | 516,615 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2015 | 94,573 | 611,188 | - | - | Common Shares | |
| James R. Neal | Other | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2015 | 9,067 | 175,402 | - | - | Common Shares | |
| Julian C. Baker | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Jul 2015 | 229,436 | 90,538 | - | - | Common Stock | |
| Julian C. Baker | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Jul 2015 | 9,411,311 | 3,153,539 | - | - | Common Stock | |
| Julian C. Baker | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Jul 2015 | 1,359,253 | 467,436 | - | - | Common Stock | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2015 | 5,000 | 127,345 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2015 | 5,000 | 27,040 | - | - | Incentive Share Option (right to buy) | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Jul 2015 | 5,000 | 122,345 | - | - | Common Shares | |
| John Varian | Director, CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Jul 2015 | 10,000 | 552,414 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2015 | 10,000 | 70,392 | - | - | Incentive Share Option (right to buy) | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2015 | 10,000 | 562,414 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2015 | 29,000 | 32,040 | - | - | Incentive Share Option (right to buy) | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Jul 2015 | 29,000 | 122,345 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2015 | 4,400 | 61,040 | - | - | Incentive Share Option (right to buy) | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2015 | 29,000 | 151,345 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2015 | 4,400 | 126,745 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Jul 2015 | 4,400 | 122,345 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2015 | 10,000 | 80,392 | - | - | Incentive Share Option (right to buy) | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2015 | 10,000 | 562,414 | - | - | Common Shares | |
| John Varian | Director, CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Jun 2015 | 10,000 | 552,414 | - | - | Common Shares | |
| Joseph M. Limber | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 67,573 | - | - | Common Shares | |
| Joseph M. Limber | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 2,800 | - | - | Restricted Stock Units | |
| William K. Bowes | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 76,539 | - | - | Common Shares | |
| William K. Bowes | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 2,800 | - | - | Restricted Stock Units | |
| William K. Bowes | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 79,339 | - | - | Common Shares | |
| William K. Bowes | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 0 | - | - | Restricted Stock Units | |
| Jack L. Wyszomierski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 78,268 | - | - | Common Shares | |
| Jack L. Wyszomierski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 75,468 | - | - | Common Shares | |
| Jack L. Wyszomierski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 2,800 | - | - | Restricted Stock Units | |
| Jack L. Wyszomierski | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 0 | - | - | Restricted Stock Units | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 4,666 | 124,133 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 4,666 | 0 | - | - | Restricted Stock Units | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 28 May 2015 | 1,788 | 122,345 | - | - | Common Shares | |
| W. Denman Van Ness | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 3,150 | 88,200 | - | - | Common Shares | |
| W. Denman Van Ness | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 3,150 | 85,050 | - | - | Common Shares | |
| W. Denman Van Ness | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 3,150 | 3,150 | - | - | Restricted Stock Units | |
| W. Denman Van Ness | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 3,150 | 0 | - | - | Restricted Stock Units | |
| Timothy P. Walbert | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 75,468 | - | - | Common Shares | |
| Timothy P. Walbert | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 0 | - | - | Restricted Stock Units | |
| Timothy P. Walbert | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 78,268 | - | - | Common Shares | |
| Timothy P. Walbert | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2015 | 2,800 | 2,800 | - | - | Restricted Stock Units | |
| Joseph M. Limber | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 36,873 | 36,873 | - | - | Non-Qualified Share Option (right to buy) | |
| Joseph M. Limber | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 36,873 | 64,773 | - | - | Common Shares | |
| William K. Bowes | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 36,873 | 36,873 | - | - | Non-Qualified Share Option (right to buy) | |
| William K. Bowes | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 36,873 | 73,739 | - | - | Common Shares | |
| Peter Barton Hutt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 73,746 | 73,746 | - | - | Non-Qualified Share Option (right to buy) | |
| Jack L. Wyszomierski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 36,873 | 36,873 | - | - | Non-Qualified Share Option (right to buy) | |
| Jack L. Wyszomierski | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 36,873 | 72,668 | - | - | Common Shares | |
| W. Denman Van Ness | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 36,873 | 36,873 | - | - | Non-Qualified Share Option (right to buy) | |
| W. Denman Van Ness | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 36,873 | 81,900 | - | - | Common Shares | |
| Timothy P. Walbert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 36,873 | 36,873 | - | - | Non-Qualified Share Option (right to buy) | |
| Timothy P. Walbert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 36,873 | 72,668 | - | - | Common Shares | |
| John Varian | Director, CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 May 2015 | 10,000 | 552,414 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2015 | 10,000 | 562,414 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2015 | 10,000 | 90,392 | - | - | Incentive Share Option (right to buy) | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2015 | 10,000 | 100,392 | - | - | Incentive Share Option (right to buy) | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2015 | 10,000 | 562,414 | - | - | Common Shares | |
| John Varian | Director, CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Apr 2015 | 10,000 | 552,414 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 4,656 | 85,454 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Apr 2015 | 1,707 | 94,031 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Apr 2015 | 5,567 | 71,929 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 3,532 | 0 | - | - | Restricted Stock Units | |
| Fred Kurland | CFO & VP Finance | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Apr 2015 | 1,707 | 95,738 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Apr 2015 | 7,414 | 77,496 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 21,750 | 0 | - | - | Restricted Stock Units | |
| Fred Kurland | CFO & VP Finance | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Apr 2015 | 9,759 | 97,445 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Apr 2015 | 7,414 | 84,910 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 4,656 | 0 | - | - | Restricted Stock Units | |
| Fred Kurland | CFO & VP Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 21,750 | 107,204 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Apr 2015 | 1,707 | 92,324 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 3,532 | 75,461 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 23 Mar 2015 | 32,742 | 119,467 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 10,875 | 80,798 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 10,875 | 21,750 | - | - | Restricted Stock Units | |
| Fred Kurland | CFO & VP Finance | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 5,233 | 69,923 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 3,930 | 75,156 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 12,141 | 172,744 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 12,141 | 12,141 | - | - | Restricted Stock Units | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 8,838 | 163,906 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 18,205 | 160,603 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 4,680 | 152,209 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 18,205 | 0 | - | - | Restricted Stock Units | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 7,017 | 156,889 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 9,500 | 124,786 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 3,433 | 121,353 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 9,500 | 9,500 | - | - | Restricted Stock Units | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 5,233 | 116,120 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 36,907 | 36,907 | - | - | Restricted Stock Units | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 36,907 | 597,291 | - | - | Common Shares | |
| John Varian | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 23,461 | 552,414 | - | - | Common Shares | |
| John Varian | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 21,416 | 575,875 | - | - | Common Shares | |
| Thomas Klein | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 667 | 80,666 | - | - | Restricted Stock Units | |
| Thomas Klein | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 44,591 | 193,753 | - | - | Common Shares | |
| Thomas Klein | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 80,000 | 238,050 | - | - | Common Shares | |
| Thomas Klein | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 8,073 | 185,680 | - | - | Common Shares | |
| Thomas Klein | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 80,000 | 81,333 | - | - | Restricted Stock Units | |
| Thomas Klein | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 373 | 238,344 | - | - | Common Shares | |
| Thomas Klein | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2015 | 667 | 238,717 | - | - | Common Shares | |
| James R. Neal | Other | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 3,521 | 189,967 | - | - | Common Shares | |
| James R. Neal | Other | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Mar 2015 | 5,498 | 184,469 | - | - | Common Shares | |
| John Varian | Director, CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Mar 2015 | 10,000 | 560,384 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2015 | 10,000 | 570,384 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2015 | 10,000 | 110,392 | - | - | Incentive Share Option (right to buy) | |
| Fred Kurland | CFO & VP Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 10,000 | 79,086 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 86,910 | 86,910 | - | - | Non-Qualified Share Option (right to buy) | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 64,900 | 142,398 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 38,940 | 115,286 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 52,146 | 52,146 | - | - | Non-Qualified Share Option (right to buy) | |
| John Varian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 266,800 | 266,800 | - | - | Non-Qualified Share Option (right to buy) | |
| John Varian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 193,200 | 560,384 | - | - | Common Shares | |
| Thomas Klein | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 64,900 | 158,050 | - | - | Common Shares | |
| Thomas Klein | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 86,910 | 86,910 | - | - | Non-Qualified Share Option (right to buy) | |
| James R. Neal | Other | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 52,500 | 193,488 | - | - | Common Shares | |
| James R. Neal | Other | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2015 | 72,500 | 72,500 | - | - | Non-Qualified Share Option (right to buy) | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2015 | 10,000 | 377,184 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2015 | 10,000 | 120,392 | - | - | Incentive Share Option (right to buy) | |
| John Varian | Director, CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Feb 2015 | 10,000 | 367,184 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Feb 2015 | 16,000 | 69,086 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Feb 2015 | 5,000 | 76,346 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2015 | 10,000 | 130,392 | - | - | Incentive Share Option (right to buy) | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2015 | 10,000 | 377,184 | - | - | Common Shares | |
| John Varian | Director, CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Jan 2015 | 10,000 | 367,184 | - | - | Common Shares | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Jan 2015 | 4,554 | 388,063 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Jan 2015 | 118,571 | 1,851,789 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Jan 2015 | 182,454 | 14,313,038 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Jan 2015 | 21,548 | 366,515 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Jan 2015 | 118,652 | 1,970,360 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Jan 2015 | 859,988 | 12,589,950 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Jan 2015 | 25,092 | 2,089,012 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Jan 2015 | 863,100 | 13,449,938 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Jan 2015 | 21,441 | 345,074 | - | - | Common Stock | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Jan 2015 | 5,000 | 81,346 | - | - | Common Shares | |
| Fred Kurland | CFO & VP Finance | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 3,001 | 22,137 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 603 | 77,498 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 1,114 | 94,608 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 1,571 | 6,881 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 513 | 76,895 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 472 | 76,382 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 306 | 6,309 | - | - | Common Shares | |
| Patrick J. Scannon | Director, Exec. VP & CSO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 3,001 | 25,080 | - | - | Common Shares | |
| John Varian | Director, CEO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 3,001 | 18,538 | - | - | Common Shares | |
| Thomas Klein | Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 3,001 | 4,660 | - | - | Common Shares | |
| James R. Neal | Other | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 594 | 153,264 | - | - | Common Shares | |
| James R. Neal | Other | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 647 | 147,327 | - | - | Common Shares | |
| James R. Neal | Other | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 3,001 | 4,471 | - | - | Common Shares | |
| James R. Neal | Other | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 758 | 140,988 | - | - | Common Shares | |
| James R. Neal | Other | Other type of transaction at price $ 0.00 per share. | 31 Dec 2014 | 1,229 | 152,670 | - | - | Common Shares | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Dec 2014 | 112,855 | 15,022,732 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Dec 2014 | 2,825 | 405,778 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Dec 2014 | 190,117 | 14,832,615 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Dec 2014 | 26,137 | 2,160,466 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Dec 2014 | 15,420 | 2,186,603 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Dec 2014 | 337,123 | 14,495,492 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Dec 2014 | 46,362 | 2,114,104 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Dec 2014 | 8,415 | 392,617 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Dec 2014 | 4,746 | 401,032 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Dec 2014 | 81,109 | 2,310,559 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Dec 2014 | 19,599 | 2,290,960 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Dec 2014 | 590,638 | 15,925,911 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Dec 2014 | 142,543 | 15,783,368 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Dec 2014 | 647,781 | 15,135,587 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Dec 2014 | 88,937 | 2,202,023 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Dec 2014 | 3,558 | 424,785 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Dec 2014 | 16,182 | 408,603 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Dec 2014 | 14,753 | 428,343 | - | - | Common Stock | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2014 | 1,600 | 70,440 | - | - | Incentive Share Option (right to buy) | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Dec 2014 | 1,600 | 72,021 | - | - | Common Shares | |
| Paul D. Rubin | Sr. VP Clinical Dev. & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2014 | 1,600 | 73,621 | - | - | Common Shares | |
| John Varian | Director, CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Dec 2014 | 10,000 | 367,184 | - | - | Common Shares | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2014 | 10,000 | 140,392 | - | - | Incentive Share Option (right to buy) | |
| John Varian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2014 | 10,000 | 377,184 | - | - | Common Shares | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Dec 2014 | 218,383 | 17,187,779 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Dec 2014 | 5,457 | 459,878 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Dec 2014 | 29,960 | 2,483,656 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Dec 2014 | 37,592 | 2,391,668 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Dec 2014 | 274,734 | 16,516,549 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Dec 2014 | 54,396 | 2,429,260 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Dec 2014 | 9,908 | 449,970 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Dec 2014 | 6,874 | 443,096 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Dec 2014 | 396,496 | 16,791,283 | - | - | Common Stock | |
| Joseph M. Limber | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2014 | 5,600 | 27,900 | - | - | Common Shares | |
| Joseph M. Limber | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2014 | 5,600 | 5,600 | - | - | Restricted Stock Units | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Dec 2014 | 337,541 | 17,406,162 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Dec 2014 | 8,429 | 465,335 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Dec 2014 | 46,383 | 2,513,616 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Dec 2014 | 428,583 | 19,353,087 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Dec 2014 | 60,883 | 2,782,770 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Dec 2014 | 486,800 | 18,866,287 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Dec 2014 | 11,965 | 501,850 | - | - | Common Stock | |
| Julian C. Baker | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Dec 2014 | 10,534 | 513,815 | - | - | Common Stock |